MXPA05006052A - Benzimidazoles 4-sustituidos y su uso como inhibidores de secresion gastrica. - Google Patents
Benzimidazoles 4-sustituidos y su uso como inhibidores de secresion gastrica.Info
- Publication number
- MXPA05006052A MXPA05006052A MXPA05006052A MXPA05006052A MXPA05006052A MX PA05006052 A MXPA05006052 A MX PA05006052A MX PA05006052 A MXPA05006052 A MX PA05006052A MX PA05006052 A MXPA05006052 A MX PA05006052A MX PA05006052 A MXPA05006052 A MX PA05006052A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- substituted benzimidazoles
- gastric secretion
- chr8
- meaning
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 3
- -1 4-substituted benzimidazoles Chemical class 0.000 title abstract 2
- 230000028327 secretion Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invencion se refiere a benzimidazoles 6-sustituidos de la formula I, en los cuales X es O (oxigeno) o NH e Y tiene ya sea el significado -CH2-Ar en donde Ar es un residuo aromatico mono- o bi-ciclico, o Y denota el grupo gp, formula (gp) en donde Z tiene el significado -CHR8- o -CHR8-CHR9-. Los compuestos tienen inhibicion de la secrecion gastrica y excelentes propiedades de accion protectora intestinal y gastrica.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02027874 | 2002-12-13 | ||
EP03021348 | 2003-09-20 | ||
PCT/EP2003/014069 WO2004054984A1 (en) | 2002-12-13 | 2003-12-11 | 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05006052A true MXPA05006052A (es) | 2005-08-18 |
Family
ID=32598782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05006052A MXPA05006052A (es) | 2002-12-13 | 2003-12-11 | Benzimidazoles 4-sustituidos y su uso como inhibidores de secresion gastrica. |
Country Status (19)
Country | Link |
---|---|
US (1) | US20060194969A1 (es) |
EP (1) | EP1575924A1 (es) |
JP (1) | JP2006511600A (es) |
KR (1) | KR20050084170A (es) |
AR (1) | AR043063A1 (es) |
AU (1) | AU2003294831A1 (es) |
BR (1) | BR0317041A (es) |
CA (1) | CA2508838A1 (es) |
CO (1) | CO5580786A2 (es) |
EA (1) | EA008779B1 (es) |
HR (1) | HRP20050612A2 (es) |
IS (1) | IS7926A (es) |
MX (1) | MXPA05006052A (es) |
NO (1) | NO20053242L (es) |
NZ (1) | NZ540862A (es) |
PL (1) | PL375820A1 (es) |
RS (1) | RS20050435A (es) |
TW (1) | TW200504031A (es) |
WO (1) | WO2004054984A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006522071A (ja) | 2003-04-04 | 2006-09-28 | アルタナ ファルマ アクチエンゲゼルシャフト | 環式ベンゾイミダゾール |
AR049168A1 (es) * | 2004-05-18 | 2006-07-05 | Altana Pharma Ag | Derivados de benzimidazol |
WO2006061380A2 (en) * | 2004-12-09 | 2006-06-15 | Altana Pharma Ag | SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS INHIBITORS OF GASTRIC ACID SECRETION |
AU2006226351A1 (en) * | 2005-03-24 | 2006-09-28 | Nycomed Gmbh | 6-thioamide substituted benzimidazoles |
ATE442140T1 (de) * | 2005-06-14 | 2009-09-15 | Raqualia Pharma Inc | Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten |
AR057061A1 (es) * | 2005-06-16 | 2007-11-14 | Altana Pharma Ag | Espiro-bencimidazoles farmaceuticamente activos y su uso en la fabricacion de medicamentos |
CA2619518A1 (en) * | 2005-08-22 | 2007-03-01 | Nycomed Gmbh | Isotopically substituted benzimidazole derivatives |
WO2007031860A1 (en) * | 2005-09-15 | 2007-03-22 | Pfizer Japan Inc. | Indane substituted benzimidazoles and their use as acid pump inhibitors |
WO2007072142A2 (en) * | 2005-12-19 | 2007-06-28 | Pfizer Japan Inc. | Benzimidazole-5-carboxamide derivatives |
EP1963311B1 (en) | 2005-12-19 | 2010-06-16 | RaQualia Pharma Inc | Chromane substituted benzimidazoles and their use as acid pump inhibitors |
WO2008017466A1 (en) * | 2006-08-08 | 2008-02-14 | Nycomed Gmbh | Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
JP5140080B2 (ja) | 2006-09-21 | 2013-02-06 | ラクオリア創薬株式会社 | 選択的アシッドポンプ阻害剤としてのベンゾイミダゾール誘導体 |
WO2008071765A1 (en) * | 2006-12-14 | 2008-06-19 | Nycomed Gmbh | Pharmaceutically active spiro-substituted benzimidazole derivatives |
WO2008084067A2 (en) * | 2007-01-12 | 2008-07-17 | Nycomed Gmbh | Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives |
WO2008151927A2 (en) * | 2007-06-15 | 2008-12-18 | Nycomed Gmbh | 6-n-substituted benz imidazole derivatives as acid pump antagonists |
MX2010002278A (es) | 2007-08-27 | 2010-03-17 | Siga Technologies Inc | Farmacos antivirales para el tratamiento de una infeccion por arenavirus. |
WO2010081670A2 (en) * | 2009-01-14 | 2010-07-22 | Lonza Ltd | Process for the preparation of benzimidazoles |
KR101605063B1 (ko) | 2009-07-09 | 2016-03-21 | 라퀄리아 파마 인코포레이티드 | 소화관 운동이상이 관여하는 질환의 치료용 산 펌프 길항제 |
WO2012081036A2 (en) * | 2010-12-13 | 2012-06-21 | Sequent Scientific Limited | A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione) |
RU2506259C1 (ru) * | 2012-12-04 | 2014-02-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный университет им. П.Г. Демидова" | Способ получения 4-{4-амино-2-хлоро-5-[(5-хлоро-2-метил-1н-бензимидазол-6-ил)амино]фенокси}бензойной кислоты |
AU2014214561C1 (en) | 2013-02-11 | 2019-01-17 | Mitokinin, Inc. | Compositions and methods for treating neurodegenerative diseases |
US9636328B2 (en) | 2013-06-21 | 2017-05-02 | Zenith Epigenetics Ltd. | Substituted bicyclic compounds as bromodomain inhibitors |
CN109939113B (zh) | 2013-06-21 | 2022-02-15 | 恒翼生物医药科技(上海)有限公司 | 双环溴结构域抑制剂 |
KR101472686B1 (ko) | 2013-07-09 | 2014-12-16 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 제조방법 |
CA2919948C (en) | 2013-07-31 | 2020-07-21 | Zenith Epigenetics Corp. | Novel quinazolinones as bromodomain inhibitors |
WO2016087936A1 (en) | 2014-12-01 | 2016-06-09 | Zenith Epigenetics Corp. | Substituted pyridinones as bromodomain inhibitors |
CA2966449A1 (en) | 2014-12-11 | 2016-06-16 | Zenith Epigenetics Ltd. | Substituted heterocycles as bromodomain inhibitors |
EP3233846A4 (en) | 2014-12-17 | 2018-07-18 | Zenith Epigenetics Ltd. | Inhibitors of bromodomains |
KR101684053B1 (ko) * | 2015-01-20 | 2016-12-08 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 신규 결정형 및 이의 제조방법 |
MY197209A (en) * | 2015-06-08 | 2023-06-01 | Raqualia Pharma Inc | Uses of benzimidazole derivative for nocturnal acid breakthrough |
KR20200019228A (ko) * | 2017-06-21 | 2020-02-21 | 미토키닌, 인크. | 신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법 |
CN113527272B (zh) * | 2021-08-06 | 2023-07-21 | 西安淳甄新材料有限公司 | 一种特戈拉赞的合成方法 |
KR20230099093A (ko) | 2021-12-27 | 2023-07-04 | 에이치케이이노엔 주식회사 | 벤즈이미다졸 유도체의 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8604566D0 (sv) * | 1986-10-27 | 1986-10-27 | Haessle Ab | Novel compunds |
IL108520A (en) * | 1993-02-15 | 1997-09-30 | Byk Gulden Lomberg Chem Fab | 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
SE9602286D0 (sv) * | 1996-06-10 | 1996-06-10 | Astra Ab | New compounds |
-
2003
- 2003-12-10 AR ARP030104544A patent/AR043063A1/es unknown
- 2003-12-11 MX MXPA05006052A patent/MXPA05006052A/es active IP Right Grant
- 2003-12-11 US US10/537,693 patent/US20060194969A1/en not_active Abandoned
- 2003-12-11 RS YUP-2005/0435A patent/RS20050435A/sr unknown
- 2003-12-11 CA CA002508838A patent/CA2508838A1/en not_active Abandoned
- 2003-12-11 JP JP2005502432A patent/JP2006511600A/ja active Pending
- 2003-12-11 PL PL03375820A patent/PL375820A1/xx not_active Application Discontinuation
- 2003-12-11 AU AU2003294831A patent/AU2003294831A1/en not_active Abandoned
- 2003-12-11 EA EA200500895A patent/EA008779B1/ru not_active IP Right Cessation
- 2003-12-11 NZ NZ540862A patent/NZ540862A/en unknown
- 2003-12-11 WO PCT/EP2003/014069 patent/WO2004054984A1/en active Application Filing
- 2003-12-11 BR BR0317041-1A patent/BR0317041A/pt unknown
- 2003-12-11 KR KR1020057010166A patent/KR20050084170A/ko not_active Application Discontinuation
- 2003-12-11 EP EP03785790A patent/EP1575924A1/en not_active Withdrawn
- 2003-12-12 TW TW092135239A patent/TW200504031A/zh unknown
-
2005
- 2005-07-01 NO NO20053242A patent/NO20053242L/no not_active Application Discontinuation
- 2005-07-01 HR HR20050612A patent/HRP20050612A2/xx not_active Application Discontinuation
- 2005-07-01 IS IS7926A patent/IS7926A/is unknown
- 2005-07-11 CO CO05067806A patent/CO5580786A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20060194969A1 (en) | 2006-08-31 |
BR0317041A (pt) | 2005-10-25 |
AR043063A1 (es) | 2005-07-13 |
NO20053242D0 (no) | 2005-07-01 |
RS20050435A (en) | 2007-08-03 |
HRP20050612A2 (en) | 2006-08-31 |
IS7926A (is) | 2005-07-01 |
PL375820A1 (en) | 2005-12-12 |
CA2508838A1 (en) | 2004-07-01 |
NO20053242L (no) | 2005-07-01 |
EP1575924A1 (en) | 2005-09-21 |
NZ540862A (en) | 2008-07-31 |
EA008779B1 (ru) | 2007-08-31 |
EA200500895A1 (ru) | 2005-12-29 |
AU2003294831A1 (en) | 2004-07-09 |
JP2006511600A (ja) | 2006-04-06 |
CO5580786A2 (es) | 2005-11-30 |
KR20050084170A (ko) | 2005-08-26 |
TW200504031A (en) | 2005-02-01 |
WO2004054984A1 (en) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20050435A (en) | 4-substituted benzimidazoles and their use as inhibitors of gastric secretion | |
WO2003106456A3 (en) | NEW COMPOUNDS | |
TW515798B (en) | Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof | |
NO20055033L (no) | Cykliske benzimidazoler | |
MY147780A (en) | Carboxamide compounds and their use as calpain inhibitors | |
MX2009005217A (es) | Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos. | |
MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
EP1794120A4 (en) | peptidase | |
MXPA04004263A (es) | Hidrazono-malonitrilos. | |
NO20052857L (no) | 8-substituerte imidazopyridiner | |
TW200616971A (en) | Condensed tricyclic benzimidazoles | |
HK1066213A1 (en) | Tricyclic imidazopyridines. | |
HRP20050794A2 (en) | 6-supstituted imidazopyrazines | |
TW200621260A (en) | Selected fused heterocyclics and uses thereof | |
TW200628153A (en) | Novel compounds | |
TW200600502A (en) | Novel 6-substituted benzimidazoles | |
HK1107984A1 (en) | Pyrrolopyridine-2-carboxylic acid amide derivativeuseful as inhibitor of glycogen phosphorylase | |
TW200611903A (en) | Substituted tricyclic benzimidazoles | |
WO2005026164A8 (en) | Pharmacologically active imidazo[4,5-c]pyridines | |
PL1651596T3 (pl) | Nowe pochodne 4,4’ - ditiobis(3-aminobutano-1-sulfonianów) i zawierające je kompozycje | |
WO2006037748A8 (en) | Substituted tricyclic benzimidazoles | |
YU34604A (sh) | Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže | |
DE60220504D1 (en) | Tryptasehemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
HH | Correction or change in general |